According to OMR analysis, the global tumor ablation market is estimated to grow significantly during the forecast period 2018-2023. The crucial factors lead to propel the growth of the market includes increasing demand for minimally invasive surgery, increasing incidences of cancer diseases, technological innovations in ablation devices and increasing healthcare spending.
Furthermore, the global tumor ablation market is segmented on the basis of technology, application, end-user and regional outlook. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
To Request a Sample of our Tumor Ablation Market: https://www.omrglobal.com/request-sample/tumor-ablation-market
A significant rise in incidences of cancer is primarily driving the growth of the market. According to the National Cancer Institute (NCI), in 2018, an estimated 1,735,350 new cancer incidences will be diagnosed in the US. As per their estimation, in the US, the most common cancer cases in 2018 include breast cancer, prostate cancer, colorectal cancer, bladder cancer, melanoma of the skin. Other most common cancer diseases comprise pancreatic cancer, endometrial cancer, kidney and renal pelvis cancer and leukemia. Based on 2011-2015 cases, each year, the number of new cancer incidence is 439.2 per 100,000 men and women in the US. According to NCI, in 2016, there were approximately 15.5 million cancer survivors in the US, which is estimated to increase to 20.3 million by 2026.
This represents significant awareness among cancer patients for the treatment of the condition. As a result, it enables to propel the growth of the market. Tumor ablation is referred to as a minimally invasive technique for the treatment of solid tumors. For liver cancer, ablation as a treatment enables to destroy liver tumors without removing them. One of the major ablation techniques used for the treatment of cancer comprises radiofrequency (RFA) ablation. It uses radiofrequency waves to kill cancer cells. Under the procedure, the doctor places a small, needle-like probe into the tumor. Later, through the tip of the probe, a high-frequency current is passed that enables to destroy cancer cells. It is a frequently used method for small tumors. Furthermore, it is a part of minimally invasive procedures that is highly preferred among hospitals and patients due to safety and effectiveness. This, in turn, is boosting the global tumor ablation market.
(Get 15% Discount on Buying this Report)
A full Report of Tumor Ablation Market is Available at: https://www.omrglobal.com/industry-reports/tumor-ablation-market
The Report Covers
- Comprehensive research methodology of global tumor ablation market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global tumor ablation market.
- Insights about market determinants which are stimulating the global tumor ablation market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- Rest of APAC
Rest of The World
Company Profiles
- Adagio Medical, Inc.
- Afreeze GmbH
- Alpinion Medical Systems Co., Ltd.
- Arrinex, Inc.
- Atricure, Inc.
- ATS Medical, Inc.
- Biosig Technologies, Inc.
- Biotronik, Inc.
- Boston Scientific Corp.
- BTG Plc
- BVM Medical Ltd
- C2 Therapeutics, Inc.
- Coopersurgical Inc.
- Endocare, Inc.
- Erbe Elektromedizin GmbH
- Galil Medical Inc
- Healthtronics, Inc.
- Icecure Medical Ltd
- Integra Lifesciences Holdings Corp.
- Koninklijke Philips N.V
- Medtronic Plc
- Medwaves Inc.
- Sanarus Technologies, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/tumor-ablation-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
